Compile Data Set for Download or QSAR
Report error Found 95 Enz. Inhib. hit(s) with all data for entry = 11413
TargetReplicase polyprotein 1a(2019-nCoV)
Insilico Medicine Ip

US Patent
LigandPNGBDBM613630(US11731944, Example 100a)
Affinity DataIC50: 100nMAssay Description:The C-His6-tagged SARS-CoV-2 MPRO (NC_045512) was cloned, expressed in E. coli, and purified by WuXi. The substrate of Dabcyl-KTSAVLQIISGFRKME-(Edans...More data for this Ligand-Target Pair
In Depth
Date in BDB:
9/26/2023
Entry Details
Go to US Patent

TargetReplicase polyprotein 1a(2019-nCoV)
Insilico Medicine Ip

US Patent
LigandPNGBDBM613639(US11731944, Example 105a)
Affinity DataIC50: 100nMAssay Description:The C-His6-tagged SARS-CoV-2 MPRO (NC_045512) was cloned, expressed in E. coli, and purified by WuXi. The substrate of Dabcyl-KTSAVLQIISGFRKME-(Edans...More data for this Ligand-Target Pair
In Depth
Date in BDB:
9/26/2023
Entry Details
Go to US Patent

TargetReplicase polyprotein 1a(2019-nCoV)
Insilico Medicine Ip

US Patent
LigandPNGBDBM613590(US11731944, Example 23b)
Affinity DataIC50: 100nMAssay Description:The C-His6-tagged SARS-CoV-2 MPRO (NC_045512) was cloned, expressed in E. coli, and purified by WuXi. The substrate of Dabcyl-KTSAVLQIISGFRKME-(Edans...More data for this Ligand-Target Pair
In Depth
Date in BDB:
9/26/2023
Entry Details
Go to US Patent

TargetReplicase polyprotein 1a(2019-nCoV)
Insilico Medicine Ip

US Patent
LigandPNGBDBM613637(US11731944, Example 104a)
Affinity DataIC50: 100nMAssay Description:The C-His6-tagged SARS-CoV-2 MPRO (NC_045512) was cloned, expressed in E. coli, and purified by WuXi. The substrate of Dabcyl-KTSAVLQIISGFRKME-(Edans...More data for this Ligand-Target Pair
In Depth
Date in BDB:
9/26/2023
Entry Details
Go to US Patent

TargetReplicase polyprotein 1a(2019-nCoV)
Insilico Medicine Ip

US Patent
LigandPNGBDBM613635(US11731944, Example 103a)
Affinity DataIC50: 100nMAssay Description:The C-His6-tagged SARS-CoV-2 MPRO (NC_045512) was cloned, expressed in E. coli, and purified by WuXi. The substrate of Dabcyl-KTSAVLQIISGFRKME-(Edans...More data for this Ligand-Target Pair
In Depth
Date in BDB:
9/26/2023
Entry Details
Go to US Patent

TargetReplicase polyprotein 1a(2019-nCoV)
Insilico Medicine Ip

US Patent
LigandPNGBDBM613595(US11731944, Example 28a)
Affinity DataIC50: 100nMAssay Description:The C-His6-tagged SARS-CoV-2 MPRO (NC_045512) was cloned, expressed in E. coli, and purified by WuXi. The substrate of Dabcyl-KTSAVLQIISGFRKME-(Edans...More data for this Ligand-Target Pair
In Depth
Date in BDB:
9/26/2023
Entry Details
Go to US Patent

TargetReplicase polyprotein 1a(2019-nCoV)
Insilico Medicine Ip

US Patent
LigandPNGBDBM613633(US11731944, Example 102a)
Affinity DataIC50: 100nMAssay Description:The C-His6-tagged SARS-CoV-2 MPRO (NC_045512) was cloned, expressed in E. coli, and purified by WuXi. The substrate of Dabcyl-KTSAVLQIISGFRKME-(Edans...More data for this Ligand-Target Pair
In Depth
Date in BDB:
9/26/2023
Entry Details
Go to US Patent

TargetReplicase polyprotein 1a(2019-nCoV)
Insilico Medicine Ip

US Patent
LigandPNGBDBM613599(US11731944, Example 32a)
Affinity DataIC50: 100nMAssay Description:The C-His6-tagged SARS-CoV-2 MPRO (NC_045512) was cloned, expressed in E. coli, and purified by WuXi. The substrate of Dabcyl-KTSAVLQIISGFRKME-(Edans...More data for this Ligand-Target Pair
In Depth
Date in BDB:
9/26/2023
Entry Details
Go to US Patent

TargetReplicase polyprotein 1a(2019-nCoV)
Insilico Medicine Ip

US Patent
LigandPNGBDBM613632(US11731944, Example 101a)
Affinity DataIC50: 100nMAssay Description:The C-His6-tagged SARS-CoV-2 MPRO (NC_045512) was cloned, expressed in E. coli, and purified by WuXi. The substrate of Dabcyl-KTSAVLQIISGFRKME-(Edans...More data for this Ligand-Target Pair
In Depth
Date in BDB:
9/26/2023
Entry Details
Go to US Patent

TargetReplicase polyprotein 1a(2019-nCoV)
Insilico Medicine Ip

US Patent
LigandPNGBDBM613601(US11731944, Example 33a)
Affinity DataIC50: 100nMAssay Description:The C-His6-tagged SARS-CoV-2 MPRO (NC_045512) was cloned, expressed in E. coli, and purified by WuXi. The substrate of Dabcyl-KTSAVLQIISGFRKME-(Edans...More data for this Ligand-Target Pair
In Depth
Date in BDB:
9/26/2023
Entry Details
Go to US Patent

TargetReplicase polyprotein 1a(2019-nCoV)
Insilico Medicine Ip

US Patent
LigandPNGBDBM613603(US11731944, Example 34a)
Affinity DataIC50: 100nMAssay Description:The C-His6-tagged SARS-CoV-2 MPRO (NC_045512) was cloned, expressed in E. coli, and purified by WuXi. The substrate of Dabcyl-KTSAVLQIISGFRKME-(Edans...More data for this Ligand-Target Pair
In Depth
Date in BDB:
9/26/2023
Entry Details
Go to US Patent

TargetReplicase polyprotein 1a(2019-nCoV)
Insilico Medicine Ip

US Patent
LigandPNGBDBM613605(US11731944, Example 36a)
Affinity DataIC50: 100nMAssay Description:The C-His6-tagged SARS-CoV-2 MPRO (NC_045512) was cloned, expressed in E. coli, and purified by WuXi. The substrate of Dabcyl-KTSAVLQIISGFRKME-(Edans...More data for this Ligand-Target Pair
In Depth
Date in BDB:
9/26/2023
Entry Details
Go to US Patent

TargetReplicase polyprotein 1a(2019-nCoV)
Insilico Medicine Ip

US Patent
LigandPNGBDBM613564(US11731944, Example 1a)
Affinity DataIC50: 100nMAssay Description:The C-His6-tagged SARS-CoV-2 MPRO (NC_045512) was cloned, expressed in E. coli, and purified by WuXi. The substrate of Dabcyl-KTSAVLQIISGFRKME-(Edans...More data for this Ligand-Target Pair
In Depth
Date in BDB:
9/26/2023
Entry Details
Go to US Patent

TargetReplicase polyprotein 1a(2019-nCoV)
Insilico Medicine Ip

US Patent
LigandPNGBDBM613607(US11731944, Example 76a)
Affinity DataIC50: 100nMAssay Description:The C-His6-tagged SARS-CoV-2 MPRO (NC_045512) was cloned, expressed in E. coli, and purified by WuXi. The substrate of Dabcyl-KTSAVLQIISGFRKME-(Edans...More data for this Ligand-Target Pair
In Depth
Date in BDB:
9/26/2023
Entry Details
Go to US Patent

TargetReplicase polyprotein 1a(2019-nCoV)
Insilico Medicine Ip

US Patent
LigandPNGBDBM613628(US11731944, Example 99a)
Affinity DataIC50: 100nMAssay Description:The C-His6-tagged SARS-CoV-2 MPRO (NC_045512) was cloned, expressed in E. coli, and purified by WuXi. The substrate of Dabcyl-KTSAVLQIISGFRKME-(Edans...More data for this Ligand-Target Pair
In Depth
Date in BDB:
9/26/2023
Entry Details
Go to US Patent

TargetReplicase polyprotein 1a(2019-nCoV)
Insilico Medicine Ip

US Patent
LigandPNGBDBM613611(US11731944, Example 77a)
Affinity DataIC50: 100nMAssay Description:The C-His6-tagged SARS-CoV-2 MPRO (NC_045512) was cloned, expressed in E. coli, and purified by WuXi. The substrate of Dabcyl-KTSAVLQIISGFRKME-(Edans...More data for this Ligand-Target Pair
In Depth
Date in BDB:
9/26/2023
Entry Details
Go to US Patent

TargetReplicase polyprotein 1a(2019-nCoV)
Insilico Medicine Ip

US Patent
LigandPNGBDBM613612(US11731944, Example 77b)
Affinity DataIC50: 100nMAssay Description:The C-His6-tagged SARS-CoV-2 MPRO (NC_045512) was cloned, expressed in E. coli, and purified by WuXi. The substrate of Dabcyl-KTSAVLQIISGFRKME-(Edans...More data for this Ligand-Target Pair
In Depth
Date in BDB:
9/26/2023
Entry Details
Go to US Patent

TargetReplicase polyprotein 1a(2019-nCoV)
Insilico Medicine Ip

US Patent
LigandPNGBDBM613626(US11731944, Example 98a)
Affinity DataIC50: 100nMAssay Description:The C-His6-tagged SARS-CoV-2 MPRO (NC_045512) was cloned, expressed in E. coli, and purified by WuXi. The substrate of Dabcyl-KTSAVLQIISGFRKME-(Edans...More data for this Ligand-Target Pair
In Depth
Date in BDB:
9/26/2023
Entry Details
Go to US Patent

TargetReplicase polyprotein 1a(2019-nCoV)
Insilico Medicine Ip

US Patent
LigandPNGBDBM613615(US11731944, Example 90a)
Affinity DataIC50: 100nMAssay Description:The C-His6-tagged SARS-CoV-2 MPRO (NC_045512) was cloned, expressed in E. coli, and purified by WuXi. The substrate of Dabcyl-KTSAVLQIISGFRKME-(Edans...More data for this Ligand-Target Pair
In Depth
Date in BDB:
9/26/2023
Entry Details
Go to US Patent

TargetReplicase polyprotein 1a(2019-nCoV)
Insilico Medicine Ip

US Patent
LigandPNGBDBM613617(US11731944, Example 92a)
Affinity DataIC50: 100nMAssay Description:The C-His6-tagged SARS-CoV-2 MPRO (NC_045512) was cloned, expressed in E. coli, and purified by WuXi. The substrate of Dabcyl-KTSAVLQIISGFRKME-(Edans...More data for this Ligand-Target Pair
In Depth
Date in BDB:
9/26/2023
Entry Details
Go to US Patent

TargetReplicase polyprotein 1a(2019-nCoV)
Insilico Medicine Ip

US Patent
LigandPNGBDBM613619(US11731944, Example 94a)
Affinity DataIC50: 100nMAssay Description:The C-His6-tagged SARS-CoV-2 MPRO (NC_045512) was cloned, expressed in E. coli, and purified by WuXi. The substrate of Dabcyl-KTSAVLQIISGFRKME-(Edans...More data for this Ligand-Target Pair
In Depth
Date in BDB:
9/26/2023
Entry Details
Go to US Patent

TargetReplicase polyprotein 1a(2019-nCoV)
Insilico Medicine Ip

US Patent
LigandPNGBDBM613624(US11731944, Example 97a)
Affinity DataIC50: 100nMAssay Description:The C-His6-tagged SARS-CoV-2 MPRO (NC_045512) was cloned, expressed in E. coli, and purified by WuXi. The substrate of Dabcyl-KTSAVLQIISGFRKME-(Edans...More data for this Ligand-Target Pair
In Depth
Date in BDB:
9/26/2023
Entry Details
Go to US Patent

TargetReplicase polyprotein 1a(2019-nCoV)
Insilico Medicine Ip

US Patent
LigandPNGBDBM613621(US11731944, Example 95a)
Affinity DataIC50: 100nMAssay Description:The C-His6-tagged SARS-CoV-2 MPRO (NC_045512) was cloned, expressed in E. coli, and purified by WuXi. The substrate of Dabcyl-KTSAVLQIISGFRKME-(Edans...More data for this Ligand-Target Pair
In Depth
Date in BDB:
9/26/2023
Entry Details
Go to US Patent

TargetReplicase polyprotein 1a(2019-nCoV)
Insilico Medicine Ip

US Patent
LigandPNGBDBM613623(US11731944, Example 96a)
Affinity DataIC50: 100nMAssay Description:The C-His6-tagged SARS-CoV-2 MPRO (NC_045512) was cloned, expressed in E. coli, and purified by WuXi. The substrate of Dabcyl-KTSAVLQIISGFRKME-(Edans...More data for this Ligand-Target Pair
In Depth
Date in BDB:
9/26/2023
Entry Details
Go to US Patent

TargetReplicase polyprotein 1a(2019-nCoV)
Insilico Medicine Ip

US Patent
LigandPNGBDBM613578(US11731944, Example 8)
Affinity DataIC50: 100nMAssay Description:The C-His6-tagged SARS-CoV-2 MPRO (NC_045512) was cloned, expressed in E. coli, and purified by WuXi. The substrate of Dabcyl-KTSAVLQIISGFRKME-(Edans...More data for this Ligand-Target Pair
In Depth
Date in BDB:
9/26/2023
Entry Details
Go to US Patent

TargetReplicase polyprotein 1a(2019-nCoV)
Insilico Medicine Ip

US Patent
LigandPNGBDBM613655(US11731944, Example 113a)
Affinity DataIC50: 100nMAssay Description:The C-His6-tagged SARS-CoV-2 MPRO (NC_045512) was cloned, expressed in E. coli, and purified by WuXi. The substrate of Dabcyl-KTSAVLQIISGFRKME-(Edans...More data for this Ligand-Target Pair
In Depth
Date in BDB:
9/26/2023
Entry Details
Go to US Patent

TargetReplicase polyprotein 1a(2019-nCoV)
Insilico Medicine Ip

US Patent
LigandPNGBDBM613570(US11731944, Example 4a)
Affinity DataIC50: 100nMAssay Description:The C-His6-tagged SARS-CoV-2 MPRO (NC_045512) was cloned, expressed in E. coli, and purified by WuXi. The substrate of Dabcyl-KTSAVLQIISGFRKME-(Edans...More data for this Ligand-Target Pair
In Depth
Date in BDB:
9/26/2023
Entry Details
Go to US Patent

TargetReplicase polyprotein 1a(2019-nCoV)
Insilico Medicine Ip

US Patent
LigandPNGBDBM613572(US11731944, Example 5a)
Affinity DataIC50: 100nMAssay Description:The C-His6-tagged SARS-CoV-2 MPRO (NC_045512) was cloned, expressed in E. coli, and purified by WuXi. The substrate of Dabcyl-KTSAVLQIISGFRKME-(Edans...More data for this Ligand-Target Pair
In Depth
Date in BDB:
9/26/2023
Entry Details
Go to US Patent

TargetReplicase polyprotein 1a(2019-nCoV)
Insilico Medicine Ip

US Patent
LigandPNGBDBM613651(US11731944, Example 111a)
Affinity DataIC50: 100nMAssay Description:The C-His6-tagged SARS-CoV-2 MPRO (NC_045512) was cloned, expressed in E. coli, and purified by WuXi. The substrate of Dabcyl-KTSAVLQIISGFRKME-(Edans...More data for this Ligand-Target Pair
In Depth
Date in BDB:
9/26/2023
Entry Details
Go to US Patent

TargetReplicase polyprotein 1a(2019-nCoV)
Insilico Medicine Ip

US Patent
LigandPNGBDBM613574(US11731944, Example 6a | US11731944, Example 6b)
Affinity DataIC50: 100nMAssay Description:The C-His6-tagged SARS-CoV-2 MPRO (NC_045512) was cloned, expressed in E. coli, and purified by WuXi. The substrate of Dabcyl-KTSAVLQIISGFRKME-(Edans...More data for this Ligand-Target Pair
In Depth
Date in BDB:
9/26/2023
Entry Details
Go to US Patent

TargetReplicase polyprotein 1a(2019-nCoV)
Insilico Medicine Ip

US Patent
LigandPNGBDBM613568(US11731944, Example 3a)
Affinity DataIC50: 100nMAssay Description:The C-His6-tagged SARS-CoV-2 MPRO (NC_045512) was cloned, expressed in E. coli, and purified by WuXi. The substrate of Dabcyl-KTSAVLQIISGFRKME-(Edans...More data for this Ligand-Target Pair
In Depth
Date in BDB:
9/26/2023
Entry Details
Go to US Patent

TargetReplicase polyprotein 1a(2019-nCoV)
Insilico Medicine Ip

US Patent
LigandPNGBDBM613574(US11731944, Example 6a | US11731944, Example 6b)
Affinity DataIC50: 100nMAssay Description:The C-His6-tagged SARS-CoV-2 MPRO (NC_045512) was cloned, expressed in E. coli, and purified by WuXi. The substrate of Dabcyl-KTSAVLQIISGFRKME-(Edans...More data for this Ligand-Target Pair
In Depth
Date in BDB:
9/26/2023
Entry Details
Go to US Patent

TargetReplicase polyprotein 1a(2019-nCoV)
Insilico Medicine Ip

US Patent
LigandPNGBDBM613657(US11731944, Example 115a)
Affinity DataIC50: 100nMAssay Description:The C-His6-tagged SARS-CoV-2 MPRO (NC_045512) was cloned, expressed in E. coli, and purified by WuXi. The substrate of Dabcyl-KTSAVLQIISGFRKME-(Edans...More data for this Ligand-Target Pair
In Depth
Date in BDB:
9/26/2023
Entry Details
Go to US Patent

TargetReplicase polyprotein 1a(2019-nCoV)
Insilico Medicine Ip

US Patent
LigandPNGBDBM613649(US11731944, Example 110a)
Affinity DataIC50: 100nMAssay Description:The C-His6-tagged SARS-CoV-2 MPRO (NC_045512) was cloned, expressed in E. coli, and purified by WuXi. The substrate of Dabcyl-KTSAVLQIISGFRKME-(Edans...More data for this Ligand-Target Pair
In Depth
Date in BDB:
9/26/2023
Entry Details
Go to US Patent

TargetReplicase polyprotein 1a(2019-nCoV)
Insilico Medicine Ip

US Patent
LigandPNGBDBM613579(US11731944, Example 11a)
Affinity DataIC50: 100nMAssay Description:The C-His6-tagged SARS-CoV-2 MPRO (NC_045512) was cloned, expressed in E. coli, and purified by WuXi. The substrate of Dabcyl-KTSAVLQIISGFRKME-(Edans...More data for this Ligand-Target Pair
In Depth
Date in BDB:
9/26/2023
Entry Details
Go to US Patent

TargetReplicase polyprotein 1a(2019-nCoV)
Insilico Medicine Ip

US Patent
LigandPNGBDBM613566(US11731944, Example 2a)
Affinity DataIC50: 100nMAssay Description:The C-His6-tagged SARS-CoV-2 MPRO (NC_045512) was cloned, expressed in E. coli, and purified by WuXi. The substrate of Dabcyl-KTSAVLQIISGFRKME-(Edans...More data for this Ligand-Target Pair
In Depth
Date in BDB:
9/26/2023
Entry Details
Go to US Patent

TargetReplicase polyprotein 1a(2019-nCoV)
Insilico Medicine Ip

US Patent
LigandPNGBDBM613643(US11731944, Example 107a)
Affinity DataIC50: 100nMAssay Description:The C-His6-tagged SARS-CoV-2 MPRO (NC_045512) was cloned, expressed in E. coli, and purified by WuXi. The substrate of Dabcyl-KTSAVLQIISGFRKME-(Edans...More data for this Ligand-Target Pair
In Depth
Date in BDB:
9/26/2023
Entry Details
Go to US Patent

TargetReplicase polyprotein 1a(2019-nCoV)
Insilico Medicine Ip

US Patent
LigandPNGBDBM613587(US11731944, Example 22a)
Affinity DataIC50: 100nMAssay Description:The C-His6-tagged SARS-CoV-2 MPRO (NC_045512) was cloned, expressed in E. coli, and purified by WuXi. The substrate of Dabcyl-KTSAVLQIISGFRKME-(Edans...More data for this Ligand-Target Pair
In Depth
Date in BDB:
9/26/2023
Entry Details
Go to US Patent

TargetReplicase polyprotein 1a(2019-nCoV)
Insilico Medicine Ip

US Patent
LigandPNGBDBM613641(US11731944, Example 106a)
Affinity DataIC50: 100nMAssay Description:The C-His6-tagged SARS-CoV-2 MPRO (NC_045512) was cloned, expressed in E. coli, and purified by WuXi. The substrate of Dabcyl-KTSAVLQIISGFRKME-(Edans...More data for this Ligand-Target Pair
In Depth
Date in BDB:
9/26/2023
Entry Details
Go to US Patent

TargetReplicase polyprotein 1a(2019-nCoV)
Insilico Medicine Ip

US Patent
LigandPNGBDBM613585(US11731944, Example 18a)
Affinity DataIC50: 100nMAssay Description:The C-His6-tagged SARS-CoV-2 MPRO (NC_045512) was cloned, expressed in E. coli, and purified by WuXi. The substrate of Dabcyl-KTSAVLQIISGFRKME-(Edans...More data for this Ligand-Target Pair
In Depth
Date in BDB:
9/26/2023
Entry Details
Go to US Patent

TargetReplicase polyprotein 1a(2019-nCoV)
Insilico Medicine Ip

US Patent
LigandPNGBDBM613647(US11731944, Example 109a)
Affinity DataIC50: 100nMAssay Description:The C-His6-tagged SARS-CoV-2 MPRO (NC_045512) was cloned, expressed in E. coli, and purified by WuXi. The substrate of Dabcyl-KTSAVLQIISGFRKME-(Edans...More data for this Ligand-Target Pair
In Depth
Date in BDB:
9/26/2023
Entry Details
Go to US Patent

TargetReplicase polyprotein 1a(2019-nCoV)
Insilico Medicine Ip

US Patent
LigandPNGBDBM613583(US11731944, Example 14a)
Affinity DataIC50: 100nMAssay Description:The C-His6-tagged SARS-CoV-2 MPRO (NC_045512) was cloned, expressed in E. coli, and purified by WuXi. The substrate of Dabcyl-KTSAVLQIISGFRKME-(Edans...More data for this Ligand-Target Pair
In Depth
Date in BDB:
9/26/2023
Entry Details
Go to US Patent

TargetReplicase polyprotein 1a(2019-nCoV)
Insilico Medicine Ip

US Patent
LigandPNGBDBM613634(US11731944, Example 102b)
Affinity DataIC50: 550nMAssay Description:The C-His6-tagged SARS-CoV-2 MPRO (NC_045512) was cloned, expressed in E. coli, and purified by WuXi. The substrate of Dabcyl-KTSAVLQIISGFRKME-(Edans...More data for this Ligand-Target Pair
In Depth
Date in BDB:
9/26/2023
Entry Details
Go to US Patent

TargetReplicase polyprotein 1a(2019-nCoV)
Insilico Medicine Ip

US Patent
LigandPNGBDBM613597(US11731944, Example 29a)
Affinity DataIC50: 550nMAssay Description:The C-His6-tagged SARS-CoV-2 MPRO (NC_045512) was cloned, expressed in E. coli, and purified by WuXi. The substrate of Dabcyl-KTSAVLQIISGFRKME-(Edans...More data for this Ligand-Target Pair
In Depth
Date in BDB:
9/26/2023
Entry Details
Go to US Patent

TargetReplicase polyprotein 1a(2019-nCoV)
Insilico Medicine Ip

US Patent
LigandPNGBDBM613608(US11731944, Example 76b)
Affinity DataIC50: 550nMAssay Description:The C-His6-tagged SARS-CoV-2 MPRO (NC_045512) was cloned, expressed in E. coli, and purified by WuXi. The substrate of Dabcyl-KTSAVLQIISGFRKME-(Edans...More data for this Ligand-Target Pair
In Depth
Date in BDB:
9/26/2023
Entry Details
Go to US Patent

TargetReplicase polyprotein 1a(2019-nCoV)
Insilico Medicine Ip

US Patent
LigandPNGBDBM613631(US11731944, Example 100b)
Affinity DataIC50: 550nMAssay Description:The C-His6-tagged SARS-CoV-2 MPRO (NC_045512) was cloned, expressed in E. coli, and purified by WuXi. The substrate of Dabcyl-KTSAVLQIISGFRKME-(Edans...More data for this Ligand-Target Pair
In Depth
Date in BDB:
9/26/2023
Entry Details
Go to US Patent

TargetReplicase polyprotein 1a(2019-nCoV)
Insilico Medicine Ip

US Patent
LigandPNGBDBM613593(US11731944, Example 27a)
Affinity DataIC50: 550nMAssay Description:The C-His6-tagged SARS-CoV-2 MPRO (NC_045512) was cloned, expressed in E. coli, and purified by WuXi. The substrate of Dabcyl-KTSAVLQIISGFRKME-(Edans...More data for this Ligand-Target Pair
In Depth
Date in BDB:
9/26/2023
Entry Details
Go to US Patent

TargetReplicase polyprotein 1a(2019-nCoV)
Insilico Medicine Ip

US Patent
LigandPNGBDBM613591(US11731944, Example 26a)
Affinity DataIC50: 550nMAssay Description:The C-His6-tagged SARS-CoV-2 MPRO (NC_045512) was cloned, expressed in E. coli, and purified by WuXi. The substrate of Dabcyl-KTSAVLQIISGFRKME-(Edans...More data for this Ligand-Target Pair
In Depth
Date in BDB:
9/26/2023
Entry Details
Go to US Patent

TargetReplicase polyprotein 1a(2019-nCoV)
Insilico Medicine Ip

US Patent
LigandPNGBDBM613618(US11731944, Example 92b)
Affinity DataIC50: 550nMAssay Description:The C-His6-tagged SARS-CoV-2 MPRO (NC_045512) was cloned, expressed in E. coli, and purified by WuXi. The substrate of Dabcyl-KTSAVLQIISGFRKME-(Edans...More data for this Ligand-Target Pair
In Depth
Date in BDB:
9/26/2023
Entry Details
Go to US Patent

TargetReplicase polyprotein 1a(2019-nCoV)
Insilico Medicine Ip

US Patent
LigandPNGBDBM613653(US11731944, Example 112a)
Affinity DataIC50: 550nMAssay Description:The C-His6-tagged SARS-CoV-2 MPRO (NC_045512) was cloned, expressed in E. coli, and purified by WuXi. The substrate of Dabcyl-KTSAVLQIISGFRKME-(Edans...More data for this Ligand-Target Pair
In Depth
Date in BDB:
9/26/2023
Entry Details
Go to US Patent

Displayed 1 to 50 (of 95 total ) | Next | Last >>
Jump to: